S133: AN ENTIRELY ORAL REGIMEN OF ORAL-ATO, ATRA AND ASCORBIC ACID IN RISK-ADAPTED TREATMENT OF NEWLY-DIAGNOSED APL RESULTED IN EXCELLENT CLINICAL/MOLECULAR RESPONSES WITH DURABLE REMISSION

• Harry Gill,
• Rita Yim,
• Lynn Chin,
• Paul Lee,
• Vivian LI,
• Lester Au,
• Man Kit Garret Leung,
• Cyrus Kumana,
• Yok Lam Kwong

Affiliations

Harry Gill

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Rita Yim

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Lynn Chin

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Paul Lee

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Vivian LI

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Lester Au

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Man Kit Garret Leung

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Cyrus Kumana

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong

Yok Lam Kwong

1 LKS Faculty of Medicine, the University of Hong Kong, Department of Medicine, School of Clinical Medicine, Hong Kong, Hong Kong